tirzepatide and menopause Tirzepatide, Hormone Therapy Combination Increases Weight Loss in Postmenopausal Women Understanding the Impact of Tirzepatide

When the scientists tried to patent exendin-4 as a diabetes treatment, pharmaceutical companies weren't interested they didn't want to give people a hormone mimic derived from a venomous lizard

GLP-1 receptor agonists: reminder of potential side effects and awareness of potential for misuse

For example, injecting 100 units of a low-concentration liquid might be uncomfortable, so the pharmacy creates a higher-concentration liquid so the patient only needs to inject 25 or 50 units to get the same amount of active medication

This vulnerability is primarily due to the high content of PUFAs in their membranes, the limited availability of antioxidant enzymes, and the lack of effective DNA repair mechanisms